Beta-Blockers After Heart Attack: New 2025 Evidence and What It Means for Survivors
“New evidence from a November 2025 NEJM meta-analysis suggests routine long-term beta-blocker therapy may not benefit many heart-attack survivors with preserved heart function. Here’s what the study found, who it applies to, and how to discuss medication decisions safely with your cardiologist.”





